Sankala Group’s IQ US Large Cap R&D Leaders ETF LRND Stock Holding History

Sankala Group’s Portfolio LRND Stock Details LRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.8K	Sell	570 -7	-1%	-$277	0.02%	308
2025 Q4	$22.7K	Buy	+577	New	+$23.4K	0.02%	305

Other funds holding LRND

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sankala Group's LRND Position: Q1 2026 in Review

Sankala Group reduced its IQ US Large Cap R&D Leaders ETF (LRND) stake by 1.2% in Q1 2026, selling an estimated $277 and leaving 570 shares worth $20.8K. The position accounts for 0.02% of the portfolio, ranked #308.

Sankala Group first reported a position in LRND in Q4 2025 and has held it in 2 quarters since. The position peaked at $22.7K in Q4 2025. 5 funds tracked by Wall St. Rank hold LRND as of Q1 2026.

Sankala Group held 570 shares of IQ US Large Cap R&D Leaders ETF worth $20.8K as of Q1 2026.
Sankala Group sold 7 IQ US Large Cap R&D Leaders ETF shares in Q1 2026, an estimated $277.
IQ US Large Cap R&D Leaders ETF made up 0.02% of Sankala Group's portfolio in Q1 2026, its #308 holding.
Sankala Group first reported a position in IQ US Large Cap R&D Leaders ETF in Q4 2025 and has held it in 2 quarters since.
Sankala Group's IQ US Large Cap R&D Leaders ETF position peaked at $22.7K in Q4 2025.
5 funds tracked by Wall St. Rank held IQ US Large Cap R&D Leaders ETF as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.